FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890480480> ?p ?o ?g. }

• W2890480480 endingPage "243" @default.
• W2890480480 startingPage "235" @default.
• W2890480480 abstract "Abstract Recent studies have demonstrated the utility of drugs modulating the endogenous cannabinoid system to control excessive alcohol intake. Among them, drugs interacting with acylethanolamide receptors including cannabinoid CB1 receptor antagonists/inverse agonists, peroxisome proliferator-activated receptor alpha (PPARα) agonists or peroxisome proliferator-activated receptor gamma (PPARγ) agonists have demonstrated utility in the reduction of alcohol intake in animal models. However, few studies have addressed the potential utility of combining these classes of drugs, especially because of expected safety problems. In the present work we took the advantage of the availability of two novel dual ligands for these receptors, to test the hypothesis that these types of drugs might reproduce and even improve the pharmacological profile of those drugs interacting with single targets. To this end we tested (R)-3-[(4-Benzyl-2-oxooxazolidin-3-yl)methyl]-N-[4-(dodecylcarbamoyl)phenyl]benzamide (NF 10–360), a dual PPARα/γ agonist, and N-[1-(3,4-dihydroxyphenyl)propan-2-yl]oleamide (OLHHA), a dual CB1 receptor antagonist/PPARα agonist, in animal models of alcohol consumption. Both drugs were effective in reducing alcohol intake and alcohol self-administration, being OLHHA a very potent alcohol intake inhibitor (EC50 0.2 mg/kg). OLHHA also reduced self-administration of the opioid oxycodone. OLHHA actions on alcohol self-administration were replicated in alcohol-preferring Marchigian-Sardinian msP rats. Repeated administration of OLHHA did result neither in tolerance nor in toxicological or deleterious metabolic changes in the liver of msP rats. These data support the feasibility of developing novel dual ligands interacting with cannabinoid targets to treat alcohol use disorder in humans." @default.
• W2890480480 created "2018-09-27" @default.
• W2890480480 creator A5000664645 @default.
• W2890480480 creator A5013915946 @default.
• W2890480480 creator A5014291973 @default.
• W2890480480 creator A5015422381 @default.
• W2890480480 creator A5026940576 @default.
• W2890480480 creator A5034314111 @default.
• W2890480480 creator A5039476193 @default.
• W2890480480 creator A5047536471 @default.
• W2890480480 creator A5050914013 @default.
• W2890480480 creator A5061385316 @default.
• W2890480480 creator A5066708131 @default.
• W2890480480 creator A5086353415 @default.
• W2890480480 creator A5087857627 @default.
• W2890480480 creator A5089785370 @default.
• W2890480480 date "2018-11-01" @default.
• W2890480480 modified "2023-10-17" @default.
• W2890480480 title "PPARα/CB1 receptor dual ligands as a novel therapy for alcohol use disorder: Evaluation of a novel oleic acid conjugate in preclinical rat models" @default.
• W2890480480 cites W1526855917 @default.
• W2890480480 cites W1699530412 @default.
• W2890480480 cites W1948760417 @default.
• W2890480480 cites W1979963836 @default.
• W2890480480 cites W1979997228 @default.
• W2890480480 cites W1989073099 @default.
• W2890480480 cites W1999924323 @default.
• W2890480480 cites W2006842834 @default.
• W2890480480 cites W2016860926 @default.
• W2890480480 cites W2031322724 @default.
• W2890480480 cites W2044221469 @default.
• W2890480480 cites W2054851194 @default.
• W2890480480 cites W2062740729 @default.
• W2890480480 cites W2063388729 @default.
• W2890480480 cites W2064852078 @default.
• W2890480480 cites W2081176650 @default.
• W2890480480 cites W2085570820 @default.
• W2890480480 cites W2098434558 @default.
• W2890480480 cites W2104412023 @default.
• W2890480480 cites W2109116726 @default.
• W2890480480 cites W2139802586 @default.
• W2890480480 cites W2153143530 @default.
• W2890480480 cites W2260060905 @default.
• W2890480480 cites W2415653121 @default.
• W2890480480 cites W2528251250 @default.
• W2890480480 cites W2553011746 @default.
• W2890480480 cites W2570527954 @default.
• W2890480480 cites W2583449090 @default.
• W2890480480 cites W2618259381 @default.
• W2890480480 cites W2732821476 @default.
• W2890480480 cites W2735248943 @default.
• W2890480480 cites W2752805271 @default.
• W2890480480 cites W2765334261 @default.
• W2890480480 cites W2795837921 @default.
• W2890480480 cites W2801223828 @default.
• W2890480480 doi "https://doi.org/10.1016/j.bcp.2018.09.008" @default.
• W2890480480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30195735" @default.
• W2890480480 hasPublicationYear "2018" @default.
• W2890480480 type Work @default.
• W2890480480 sameAs 2890480480 @default.
• W2890480480 citedByCount "8" @default.
• W2890480480 countsByYear W28904804802020 @default.
• W2890480480 countsByYear W28904804802021 @default.
• W2890480480 countsByYear W28904804802022 @default.
• W2890480480 crossrefType "journal-article" @default.
• W2890480480 hasAuthorship W2890480480A5000664645 @default.
• W2890480480 hasAuthorship W2890480480A5013915946 @default.
• W2890480480 hasAuthorship W2890480480A5014291973 @default.
• W2890480480 hasAuthorship W2890480480A5015422381 @default.
• W2890480480 hasAuthorship W2890480480A5026940576 @default.
• W2890480480 hasAuthorship W2890480480A5034314111 @default.
• W2890480480 hasAuthorship W2890480480A5039476193 @default.
• W2890480480 hasAuthorship W2890480480A5047536471 @default.
• W2890480480 hasAuthorship W2890480480A5050914013 @default.
• W2890480480 hasAuthorship W2890480480A5061385316 @default.
• W2890480480 hasAuthorship W2890480480A5066708131 @default.
• W2890480480 hasAuthorship W2890480480A5086353415 @default.
• W2890480480 hasAuthorship W2890480480A5087857627 @default.
• W2890480480 hasAuthorship W2890480480A5089785370 @default.
• W2890480480 hasConcept C124952713 @default.
• W2890480480 hasConcept C134306372 @default.
• W2890480480 hasConcept C142362112 @default.
• W2890480480 hasConcept C148001335 @default.
• W2890480480 hasConcept C170493617 @default.
• W2890480480 hasConcept C185592680 @default.
• W2890480480 hasConcept C197336794 @default.
• W2890480480 hasConcept C2776885963 @default.
• W2890480480 hasConcept C2779442783 @default.
• W2890480480 hasConcept C2780980858 @default.
• W2890480480 hasConcept C2781066024 @default.
• W2890480480 hasConcept C2781403372 @default.
• W2890480480 hasConcept C33923547 @default.
• W2890480480 hasConcept C55493867 @default.
• W2890480480 hasConcept C71924100 @default.
• W2890480480 hasConcept C98274493 @default.
• W2890480480 hasConceptScore W2890480480C124952713 @default.
• W2890480480 hasConceptScore W2890480480C134306372 @default.
• W2890480480 hasConceptScore W2890480480C142362112 @default.
• W2890480480 hasConceptScore W2890480480C148001335 @default.

• next